Bayer Pursues Capital Raise Amidst Ongoing Legal Challenges

Bayer AG, the German pharmaceutical giant, is taking significant steps to manage its extensive legal challenges by seeking regulatory approval for a substantial capital increase. This decision comes as the company continues to face the financial repercussions from various lawsuits related to its herbicide Roundup, which has been linked to cancer claims.

Continue reading